Skip to main content
. Author manuscript; available in PMC: 2012 Apr 15.
Published in final edited form as: Int J Cancer. 2011 Apr 15;128(8):1946–1954. doi: 10.1002/ijc.25522

Figure 2. Effects of BMI1 silencing on Docetaxel activity.

Figure 2

A: IC50 of cells treated at different Docetaxel concentrations * p<0.05, T test. B, C: cell cycle distribution of Docetaxel-treated cells. D: Caspase 3/7 activity in LNCaP cells treated with Docetaxel at IC50 concentration for NS cells ** p<0.01, T test.